Updated:
Minneapolis Heart Institute Ventures
The firm was established by physicians at the Minneapolis Heart Institute, a leading cardiovascular care center.
Minneapolis Heart Institute Ventures
The firm was established by physicians at the Minneapolis Heart Institute, a leading cardiovascular care center. Its investment thesis centers on technologies that address unmet needs in heart disease management, drawing on clinical expertise from its founding practitioners. The strategy focuses on early-stage investments across digital health, medtech, and AI-powered diagnostics. The portfolio includes companies developing novel catheter-based therapies, cardiac monitoring wearables, and machine learning platforms for risk stratification. Geographically, the firm invests primarily in the United States, with a concentration in the Midwest and coastal tech hubs. Deployment scale and team size are not publicly disclosed. Offices in Minneapolis, Menlo Park, Palo Alto, and Boston suggest a distributed team. No recent operational events have been reported in public channels as of mid-2025. The firm's structural differentiator is its clinician-led investment model, which embeds cardiologists directly in deal sourcing and due diligence. This approach is uncommon among healthcare-focused venture firms, which typically rely on generalist investors.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Minneapolis
Corporate office
Minneapolis, MN, United States
Additional offices
Menlo Park · Palo Alto · Boston
Sector focus
Frequently asked questions
How does Minneapolis Heart Institute Ventures source deal flow?
The firm sources deals through its network of cardiologists and healthcare professionals at the Minneapolis Heart Institute and affiliated institutions. This clinical pipeline provides access to technologies developed by practitioners who identify unmet needs in cardiac care. The firm also evaluates external opportunities from academic medical centers and incubators.
What investment stages does Minneapolis Heart Institute Ventures target?
The firm focuses on early-stage investments, including seed and Series A rounds. It participates in syndicates with other healthcare-focused venture firms and occasionally co-invests alongside larger funds.
Which sectors does Minneapolis Heart Institute Ventures explicitly avoid?
The firm does not invest in drug development, pharmaceutical trials, or generalist healthcare services. Its mandate is limited to cardiovascular-focused medical devices, digital health platforms, and AI/ML-enabled diagnostic tools.
Is Minneapolis Heart Institute Ventures structured as a single family office or a venture firm?
Public records indicate it operates as a venture investment firm rather than a family office. Its structure is clinician-led, with investment decisions guided by practicing cardiologists rather than a single wealthy family.
Does Minneapolis Heart Institute Ventures maintain philanthropic structures?
No separate philanthropic entity has been publicly disclosed. The Minneapolis Heart Institute Foundation, a related nonprofit, funds cardiovascular research and education, but its relationship to the venture arm is not formally documented.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: